Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?
You’re invited to join our “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now. MGFA is offering this online webinar program series to anyone interested in learning more about this ongoing MG research in investigative therapies. We hope you’ll register for the latest update.
Webinar Presentation of Newly FDA Approved VYVGART™
Date/Time: Tuesday, February 22nd 2022 at 3:00 p.m. Eastern
Presenter: Dr. Deborah Gelinas, MD, Executive Director of Neuromuscular Medicine for Argenx.
Webinar presentation of newly FDA Approved VYVGART™ (efgartigimod alfa-fcab) for the treatment of adult patients with gMG who are anti-AChR antibody positive
Register for This Webinar